Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer.

ABSTRACT:

SUBMITTER: Chen X 

PROVIDER: S-EPMC10352603 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature